#everest medicines

Collection of everest medicines news, found 2 news.

Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market

Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market

  • 5th June 2026

 Everest Medicines (HKEX 1952.HK) announced that it has entered into a commercialization license agreement with ...

Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases, Driving Value Conversion

Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases, Driving Value Conversion

  • 5th June 2026

 Everest Medicines (HKEX 1952.HK) announced that it has entered into an exclusive licensing and collaboration ...